BenevolentAI: Publication of the Revised Agenda for the 2024 AGM
April 17 2024 - 1:00AM
Business Wire
Regulatory News:
BenevolentAI (“BenevolentAI” or the “Company”) (Euronext
Amsterdam: BAI), a leader in applying advanced AI to accelerate
biopharma drug discovery, today announces the publication of the
Revised Agenda for its Annual General Meeting set to be held on 2
May 2024 at 14:00 CEST at 2, place Winston Churchill, L-1340
Luxembourg (the “2024 AGM”) (the “Revised Agenda”).
The Revised Agenda, the revised proxy form and all other meeting
documentation are now available on the Company’s website
(www.benevolent.com/investors/general-meetings/) and at the
Company’s registered office.
The shareholders entitled to participate and vote at the 2024
AGM will be those who are shareholders on the record date of 18
April 2024 at 24:00 (midnight) CEST.
About BenevolentAI
At BenevolentAI (AMS: BAI), we serve patients by leveraging our
proprietary and validated Benevolent PlatformTM that integrates AI
and science to uncover new biology, predict novel targets and
develop first-in-class or best-in-class drugs for complex diseases.
By applying proprietary advanced AI tools, in combination with
in-house scientific expertise and wet-lab facilities, BenevolentAI
is well-positioned to identify and accelerate novel drug discovery.
The Company’s business model presents multiple routes for value
creation including discovery collaborations with pharma companies
like AstraZeneca and Merck, advancing in-house pipelines to
inflection points, and commercialising a suite of knowledge
exploration tools. Headquartered in London, with wet labs in
Cambridge (UK) and an office in New York, BenevolentAI is at the
forefront of reshaping the future of drug discovery and delivering
innovative medicines.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240416383292/en/
Enquiries: Investors: Fleur
Wood – VP Investor Relations fleur.wood@benevolent.ai
investors@benevolent.ai T: +44(0) 203 781 9360 Company
Secretary: Judit Molnar – Deputy Company Secretary
cosec@benevolent.ai T: +44(0) 203 781 9360